Alexandria Venture Investments Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 4
- Investments
- 222
- Portfolio
- 102
- Exits
- 66
Alexandria Venture Investments General Information
Description
Founded in 1996, Alexandria Venture Investments is the corporate venture capital arm of Alexandria Real Estate Equities and is based in Pasadena, California. The firm provides long-term strategic investment capital to innovative companies operating in the biopharma, life science, diagnostics, technology, research tools, and ag-tech sectors.
Contact Information
Year Founded
1996
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
- 26 North Euclid Avenue
- Pasadena, CA 91101
- United States
+1 (626) 000-0000
Alexandria Venture Investments Investments (222)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ubiq (Cybersecurity Platform) | 19-Nov-2020 | Seed Round | 00.00 | Network Management Software | Generating Revenue | |
| 000000 00000000000 | 30-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 000000000 00000000 | 25-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 0000000 0000000000 | 15-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 0000 000 | 11-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 00000 000 | 10-Sep-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000000 000 | 10-Aug-2020 | 00000 00000 | 00.00 | Drug Discovery | Startup | |
| 00000000 | 10-Aug-2020 | 0000 00000 | 00.00 | Drug Discovery | Generating Revenue | |
| Vesigen Therapeutics | 25-Jul-2020 | Early Stage VC | 000.00 | Drug Delivery | Startup | |
| Vor Biopharma | 07-Jul-2020 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue |
Alexandria Venture Investments Exits (65)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cibus | 29-Oct-2020 | Merger/Acquisition | |
| 000000 | 14-Oct-2020 | 000 | 000.00 |
| 000000000 | 16-Sep-2020 | 000 | 0000 |
| 0000000 | 19-Aug-2020 | 000 | 00000 |
| 00000 000000000000 | 16-Jul-2020 | 000 | 00000 |
| 00000000 000000 | 15-Jun-2020 | 000 | 00000 |
| 0000000 0000000000 | 12-Jun-2020 | 000 | 00000 |
| 00000 | 12-Mar-2020 | 000 | 000.00 |
| Nohla Therapeutics | 01-Nov-2019 | Out of Business | |
| Frequency Therapeutics | 03-Oct-2019 | IPO | 0000 |
Alexandria Venture Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAlexandria Venture Investments Team (9)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kristen Childs | Executive | Pasadena, CA | |||
| Monica Beam Ph.D | Senior Vice President | 0 | 0 | Pasadena, CA | |
| Jenna Foger | Senior Vice President, Science & Technology | 0 | 0 | Pasadena, CA | |
| Aaron Jacobson | Vice President of Corporate Counsel | Pasadena, CA | |||
| Peter Moglia | Co-Chief Executive Officer | Pasadena, CA |
Alexandria Venture Investments Co-Investors (501)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 27 | 0 | 0 |
|
|
| Pfizer Ventures | 00 | 0 | 00 |
|
|
| GV | 00 | 0 | 0 |
|
|
| AbbVie Ventures | 00 | 0 |
|
|
|
| Casdin Capital | 00 | 0 |
|
|